Corrigendum: Efficacy and safety of intravitreal injection of aflibercept biosimilar for treating diabetic macular edema

Corrigendum: Efficacy and safety of intravitreal injection of aflibercept biosimilar for treating diabetic macular edema

Saved in:

Bibliographic Details
Main Authors:	Gaixia Zhai, Chao Sun, Xia Zhang, Yuanzhen Su
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-05-01
Series:	Frontiers in Medicine
Subjects:	aflibercept biosimilar diabetic macular edema foveal avascular zone vascular density multifocal electroretinography
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2025.1620932/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and safety of intravitreal injection of aflibercept biosimilar for treating diabetic macular edema
by: Gaixia Zhai, et al.
Published: (2025-03-01)

Transitioning from Aflibercept to Biosimilar Ranibizumab in Diabetic Macular Edema (DME): (The TRANSFORM-DME Trial) a Multicenter Observational Study
by: Chakraborty D, et al.
Published: (2024-11-01)

Efficacy and safety of dexamethasone versus intravitreal aflibercept implants for macular edema: a systematic review and meta-analysis
by: Khaled Moghib, et al.
Published: (2025-04-01)

Experiences of using Aflibercept in diabetic macular edema treatment: data from routine clinical practice
by: E. Yu. Santoro
Published: (2018-12-01)

Efficacy and Safety of Aflibercept Biosimilars Relative to Reference Aflibercept Therapy for Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis
by: Aljuhani HS, et al.
Published: (2025-06-01)

Comparative Efficacy of Intravitreal Aflibercept and Dexamethasone Implant in Treating Macular Edema Associated with Diabetic Retinopathy or Retinal Vein Occlusion: A Meta-Analysis and Systematic Review
by: Khaled Moghib, et al.
Published: (2025-01-01)

Brolucizumab versus aflibercept for recalcitrant diabetic macular edema in Indian real-world scenario – The BRADIR study
by: Debdulal Chakraborty, et al.
Published: (2024-12-01)

Efficacy of Aflibercept (8 mg) for Diabetic Macular Edema in Vitrectomized Eyes Refractory to the Other Anti-VEGF Drug Therapies: A Report of Three Cases
by: Kashiwagi I, et al.
Published: (2025-04-01)

Effect of multiple intravitreal injections of conbercept on the cornea in patients with branch retinal vein occlusion-induced macular edema
by: Gaixia Zhai, et al.
Published: (2025-06-01)

Intravitreal Ranibizumab versus Razumab in treatment naïve diabetic macular edema
by: Dhandapani A, et al.
Published: (2025-06-01)

Patterns of Foveal Eversion in Patients with Diabetic Macular Edema
by: E. Yu. Santoro, et al.
Published: (2025-03-01)

Impact of Subthreshold Micropulse Laser on the Vascular Network in Diabetic Macular Edema: An Optical Coherence Tomography Angiography Study
by: Barbara Sabal, et al.
Published: (2025-05-01)

Short-term outcomes of faricimab and aflibercept 8 mg in diabetic macular edema
by: Carlo Maccauro, et al.
Published: (2025-07-01)

Nonclinical Similarity of the Biosimilar Candidate ABP 938 with Aflibercept Reference Product
by: Neungseon Seo, et al.
Published: (2024-11-01)

Intravitreal Injections for Macular Edema in Silicone Oil Filled Eyes
by: Safadi K, et al.
Published: (2024-11-01)

Differences in macular structure and microvasculature between high myopia and non-high myopia
by: Qin Chen, et al.
Published: (2025-08-01)

Effectiveness of aflibercept in treating bevacizumab resistant macular edema
by: Hussain Khudair Yassin
Published: (2024-12-01)

12-month outcomes of ziv-aflibercept for neovascular age-related macular degeneration in eyes previously treated with aflibercept
by: Wajiha J Kheir, et al.
Published: (2025-01-01)

Two-year results of switching to intravitreal administration of faricimab in patients with aflibercept-refractory neovascular age-related macular degeneration
by: Masaaki Saito, et al.
Published: (2025-08-01)

Changes of retinal ganglion cell–inner plexiform layer thickness and visual acuity in patients with diabetic macular edema treated with Aflibercept
by: Mouna M. Alsaad, et al.
Published: (2025-01-01)

One-Year Outcomes of Aflibercept in Treat-and-Extend Versus Pro Re Nata Regimens for Bevacizumab-Resistant Diabetic Macular Edema: A Real-World Study
by: Zubeyir Yozgat, et al.
Published: (2024-11-01)

Tomographic Parameters of Recurrent Macular Edema Due to Retinal Vein Occlusion during Antiangiogenic Therapy
by: D. Yu. Khokhlova, et al.
Published: (2021-10-01)

Correlating the Optical Coherence Tomography Patterns and Biomarkers of Diabetic Macular Edema with Hemoglobin Level in Diabetic Kidney Disease
by: Gopalakrishnan N, et al.
Published: (2025-01-01)

Suprachoroidal Versus Intravitreal Injection of Triamcinolone Acetonide As Primary Treatment For Diabetic Macular Edema
by: Fatima Shafqat Khan, et al.
Published: (2023-12-01)

Resveratrol Supplementation in Wet AMD: Association With Fewer Intravitreal Injections and Reduced Macular Fibrosis
by: Datseris I, et al.
Published: (2025-01-01)

THE FIRST EXPERIENCE OF USING ANTI-VEGF THERAPY PRIOR TO CATARACT SURGERY IN PATIENTS WITH DIABETIC MACULAR EDEMA
by: N. A. Malysheva
Published: (2018-10-01)

Intravitreal Dexamethasone Implant in the Treatment of Refractory Uveitic Macular Edema: A Case Report
by: Anisha Seth, et al.
Published: (2016-04-01)

Optical Coherence Tomography Angiography Changes in Diabetic Macular Ischemia after Systemic Normobaric Oxygen Therapy
by: Diba Idani, et al.
Published: (2025-05-01)

Efficacy of intravitreal injection of Ziv-aflibercept before vitrectomy for proliferative diabetic retinopathy
by: Amin E. Nawar, et al.
Published: (2024-04-01)

Objective Determination of Retinal Function in Bietti Crystalline Retinopathy
by: Dorukcan Akıncıoğlu, et al.
Published: (2016-06-01)

Evaluation of topical bromfenac as an adjunctive treatment with intravitreal ranibizumab in the management of diabetic macular edema
by: Sara S. Emara, et al.
Published: (2024-10-01)

Effect of combined mature cataract surgery and intravitreal ranibizumab injection in eyes with pre-existing diabetic macular edema
by: Yao Shen, et al.
Published: (2025-08-01)

Risk factors and Response of Branch Retinal Vein Occlusion induced Macular Edema to intravitreal injections of Triamcinolone and Bevacizumab
by: Singhai Prakhar, et al.
Published: (2017-07-01)

Early optical coherence tomography biomarkers for tailored frequency of intravitreal aflibercept in neovascular age-related macular degeneration
by: Gyeongsoo Lim, et al.
Published: (2025-03-01)

Outcomes of intravitreal dexamethasone implant (Ozurdex®) in patients with post-surgical macular edema – a real-world scenario
by: Elder Ohara de Oliveira Júnior, et al.
Published: (2025-01-01)

Real-world clinical insights and aqueous humor biomarker analysis of diabetic macular edema subtypes classified by OCT following intravitreal injections
by: Liangzhang Tan, et al.
Published: (2025-07-01)

Revisiting the Role of Intravitreal Triamcinolone in Diabetic Macular Edema: 12-Month Outcomes after Bevacizumab Failure
by: Sukhum Silpa-archa, et al.
Published: (2025-06-01)

Retinal thickness and macular microvascular changes seen on optical coherence tomography angiography (OCTA) in patients with sickle cell retinopathy in a tertiary care eye hospital
by: Olufemi Oderinlo, et al.
Published: (2024-12-01)

Postoperative, or pseudophakic, macular edema
by: I. E. Ioshin
Published: (2020-12-01)

The role of optical coherence tomography angiography biomarkers in assessing the outcome of long-term anti-VEGF therapy of diabetic macular edema
by: A. Zh. Fursova, et al.
Published: (2022-01-01)